Bill115th CongressFiled May 4, 2017Health
H.R. 2376
Drug Diversion and Counterfeit Crackdown Act of 2017
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (May 4, 2017)
Drug Diversion and Counterfeit Crackdown Act of 2017
This bill makes it illegal except in cases of a drug shortage to import into the United States prescription drugs manufactured outside the United States and intended by the manufacturer or labeled to be marketed outside the United States.
The bill establishes a penalty for knowingly dispensing or selling a counterfeit drug.
What just happenedMay 5, 2017
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Lance, Leonard [R-NJ-7](R-NJ)Sponsor
3 cosponsors2 D1 R
3cosponsors1committees4actions2related bills5subjects
- Introduced in HouseMay 4, 2017
- May 5, 2017Committee
Referred to the Subcommittee on Health.
Health Subcommittee - May 4, 2017IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - May 4, 2017IntroReferralIntro-H
Introduced in House
- May 4, 2017IntroReferral1000
Introduced in House